What question did this study set out to answer?

To explore the biological spectrum of pediatric skeletal muscle tumors through case evaluations of rhabdomyoma and rhabdomyosarcoma.

March 28, 2026Indian Journal of Dental ResearchOpen Access

From benign to malignant: Spectrum of skeletal muscle tumors in pediatric patients – A case series

View Full Paper

Ask AI

Bookmark

To explore the biological spectrum of pediatric skeletal muscle tumors through case evaluations of rhabdomyoma and rhabdomyosarcoma.
Evaluated two pediatric cases
Utilized clinical examination and imaging modalities
Conducted histopathology and immunohistochemistry analyses
Analyzed diagnostic findings and disease progression patterns
Fetal-type rhabdomyoma showed slow growth and benign behavior
Embryonal rhabdomyosarcoma displayed aggressive invasion and systemic involvement
Distinct biological characteristics were noted despite similar clinical presentations

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Case series reveals biological differences between benign and malignant skeletal muscle tumors in children, indicating the need for accurate diagnosis.

Cite This Study

Goyal et al. (2026) studied this question.

synapsesocial.com/papers/69c7722a8bbfbc51511e2617 https://doi.org/10.4103/ijdr_202637s1_abs_166

View Full Paper

Ask AI

Bookmark

Implication

Case series reveals biological differences between benign and malignant skeletal muscle tumors in children, indicating the need for accurate diagnosis.

From benign to malignant: Spectrum of skeletal muscle tumors in pediatric patients – A case series

Key Points

Discussion

Implication

Cite This Study

From benign to malignant: Spectrum of skeletal muscle tumors in pediatric patients – A case series

Key Points

Discussion

Implication

Cite This Study

Keep reading

Keep reading